Chiron and Viagene Reach Agreement for Gene Therapy Strategic Merger.
Business Wire › April 24, 1995
Linked as:
Extract
Chiron and Viagene Reach Agreement for Gene Therapy Strategic Merger.
EMERYVILLE, Calif. and SAN DIEGO--(BUSINESS WIRE)--April 24, 1995--Chiron Corporation (NASDAQ:CHIR) and Viagene Inc. (NASDAQ:VIGN), which have had a collaboration in gene therapy, announced today that they have signed a definitive agreement to effect a strategic merger that would enable Chiron to achieve synergies of the gene therapy research, development and manufacturing capabil...
See the full content of this document
Sponsored links
